支气管动脉化疗栓塞术在肺癌咯血中的应用进展  

Progress in the Application of Bronchial Artery Chemoembolization in Hemoptysis of Lung Cancer

作　　者：胡胤 李甜甜 贾薇[1] 王连峰 

机构地区：[1]吉首大学医学院,湖南 吉首 [2]张家界市人民医院肿瘤内科,湖南 张家界

出　　处：《临床医学进展》2025年第2期428-435,共8页Advances in Clinical Medicine

基　　金：张家界市科技创新项目(2024039)。

摘　　要：肺癌的发病率逐年上升,已成为全球范围内致死率最高的恶性肿瘤之一。咯血是肺癌患者常见且危及生命的严重并发症,严重影响患者的生活质量和预后。对于大咯血的肺癌患者,内科常规治疗往往疗效不佳,外科手术的创伤较大且并发症多,而支气管动脉化疗栓塞术(BACE)作为一种有效的局部微创治疗手段,广泛应用于肺癌咯血患者。目前支气管动脉化疗栓塞术已较为成熟,治疗肺癌咯血安全有效,本文对支气管动脉化疗栓塞术在肺癌咯血治疗中的应用进行综述,论述最新的治疗进展,为临床实践提供参考。The incidence of lung cancer is increasing year by year and has become one of the most lethal malignant tumors worldwide. Hemoptysis is a common and life-threatening complication in lung cancer patients, which seriously affects their quality of life and prognosis. For patients with hemoptysis, conventional medical treatment is often ineffective, and surgery is more traumatic and has many complications. As an effective local minimally invasive treatment, bronchial artery chemoembolization (BACE) is widely used in patients with hemoptysis of lung cancer. At present, bronchial artery chemoembolization has become more mature, safe and effective in the treatment of hemoptysis in lung cancer. This article reviews the application of bronchial artery chemoembolization in the treatment of hemoptysis in lung cancer, discusses the latest therapeutic advances, and provides references for clinical practice.

关 键 词：肺癌 咯血 支气管动脉 化疗栓塞 

分 类 号：R73[医药卫生—肿瘤]